Skip to Main Content

Author Details

Tetyana I Vasylyeva
University of California
2013
39
16
PMIDPaper TitleJournal TitlePublished Year
35939177Network-level HIV risk norms are associated with individual-level HIV risk and harm reduction behaviors among people who inject drugs: a latent profile analysis.AIDS Behav2023
37658448Will the Russian war in Ukraine unleash larger epidemics of HIV, TB and associated conditions and diseases in Ukraine?Harm Reduct J2023
37502985The recency and geographical origins of the bat viruses ancestral to SARS-CoV and SARS-CoV-2.bioRxiv2023
37400776Hepatitis C Virus in people with experience of injection drug use following their displacement to Southern Ukraine before 2020.BMC Infect Dis2023
36781923Author Correction: Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021.Sci Rep2023
36896134Phylodynamics and migration data help describe HIV transmission dynamics in internally displaced people who inject drugs in Ukraine.PNAS Nexus2023
35881005The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2.Science2022
35771664Introduction and Establishment of SARS-CoV-2 Gamma Variant in New York City in Early 2021.J Infect Dis2022
35576942Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine.Lancet HIV2022
35396471Unlocking capacities of genomics for the COVID-19 response and future pandemics.Nat Methods2022
35752633Detection of SARS-CoV-2 intra-host recombination during superinfection with Alpha and Epsilon variants in New York City.Nat Commun2022
36131001Tracking SARS-COV-2 variants using Nanopore sequencing in Ukraine in 2021.Sci Rep2022
36352546Left behind on the path to 90-90-90: understanding and responding to HIV among displaced people.J Int AIDS Soc2022
33419936Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK.Science2021
33907745Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.bioRxiv2021
33893696Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations.J Viral Hepat2021
34873595Tracking SARS-COV-2 Variants Using Nanopore Sequencing in Ukraine in Summer 2021.Res Sq2021
34373458Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.Nat Commun2021
32115809Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in England.J Viral Hepat2020
33112848Locally adaptive Bayesian birth-death model successfully detects slow and rapid rate shifts.PLoS Comput Biol2020
32697423Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.J Int AIDS Soc2020
30430838The Changing Epidemiological Profile of HIV-1 Subtype B Epidemic in Ukraine.AIDS Res Hum Retroviruses2019
31245917Social network approaches to locating people recently infected with HIV in Odessa, Ukraine.J Int AIDS Soc2019
31592313People with high HIV viral load within risk networks: who are these people and who refers them best?J Infect Dev Ctries2019
30805610Tracing the Impact of Public Health Interventions on HIV-1 Transmission in Portugal Using Molecular Epidemiology.J Infect Dis2019
29339468Molecular epidemiology reveals the role of war in the spread of HIV in Ukraine.Proc Natl Acad Sci U S A2018
30101288An Innovative Study Design to Assess the Community Effect of Interventions to Mitigate HIV Epidemics Using Transmission-Chain Phylodynamics.Am J Epidemiol2018
29905915Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics.Curr HIV/AIDS Rep2018
30139911Genomic and epidemiological monitoring of yellow fever virus transmission potential.Science2018
29356365Risk network approaches to locating undiagnosed HIV cases in Odessa, Ukraine.J Int AIDS Soc2018
27451415Engagement in sex work does not increase HIV risk for women who inject drugs in Ukraine.J Public Health (Oxf)2017
27262354Integrating molecular epidemiology and social network analysis to study infectious diseases: Towards a socio-molecular era for public health.Infect Genet Evol2016
27917890A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP).Sci Rep2016
27824626Reducing HIV infection in people who inject drugs is impossible without targeting recently-infected subjects.AIDS2016
27262355The global spread of HIV-1 subtype B epidemic.Infect Genet Evol2016
25244688A new approach to prevent HIV transmission: Project Protect intervention for recently infected individuals.AIDS Care2015
25737538Prevention of early HIV transmissions might be more important in emerging or generalizing epidemics.Proc Natl Acad Sci U S A2015
24165983Socially-integrated transdisciplinary HIV prevention.AIDS Behav2014
23564029Theory, measurement and hard times: some issues for HIV/AIDS research.AIDS Behav2013
  • 1 - 39 of 39

Recommended Authors

25802Johns Hopkins Bloomberg School of Public Health
Career Start Year 2018
Number of shared co-authors 0
Sydney Institute for Infectious Diseases, The University of Sydney
Career Start Year 2016
Number of shared co-authors 4
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 0
Yale School of Medicine, USA Instituto Todos pela Saude
Career Start Year 2013
Number of shared co-authors 4
University of Nebraska Medical Center
Career Start Year 2013
Number of shared co-authors 6
Yale School of Public Health
Career Start Year 2013
Number of shared co-authors 14
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 0
Imperial College London
Career Start Year 2010
Number of shared co-authors 4
University College London Hospitals National Health Service Foundation Trust
Career Start Year 2010
Number of shared co-authors 0
University of Washington
Career Start Year 2010
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2010
Number of shared co-authors 2
Department of Epidemiology and Johns Hopkins Bloomberg School of Public Health
Career Start Year 2009
Number of shared co-authors 1
Johns Hopkins Bloomberg School of Public Health
Career Start Year 2009
Number of shared co-authors 2
Department of Health Sciences Northeastern University
Career Start Year 2009
Number of shared co-authors 6
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 2007
Number of shared co-authors 0
Institute of Medical Virology, University of Zurich
Career Start Year 2006
Number of shared co-authors 3
Fred Hutchinson Cancer Center
Career Start Year 2004
Number of shared co-authors 4
University of California San Diego
Career Start Year 2001
Number of shared co-authors 5
Centers for Disease Control and Prevention (CDC)
Career Start Year 2000
Number of shared co-authors 0
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 1
Clarkson University
Career Start Year 1999
Number of shared co-authors 1
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 1
Department of Medicine Johns Hopkins Medicine. Baltimore MD 21205USA.
Career Start Year 1996
Number of shared co-authors 1
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 0
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1993
Number of shared co-authors 0
Rollins School of Public Health, Emory University
Career Start Year 1990
Number of shared co-authors 0
Graduate School of Public Health, University of Pittsburghgrid.21925.3d
Career Start Year 1976
Number of shared co-authors 1

Collaborators

University of California
Co-authored papers 12
University of California
Co-authored papers 7
University of Cambridge
Co-authored papers 5
Co-authored papers 4
Rega Institute, Laboratory of Clinical and Evolutionary Virology
Co-authored papers 4
The Scripps Research Institute
Co-authored papers 3
University of California los angeles
Co-authored papers 3
University of California San Diego
Co-authored papers 3
University of Arizona
Co-authored papers 2
Rega Institute, University of Leuven
Co-authored papers 2
Institute of Ecology and Evolution, University of Edinburgh
Co-authored papers 2
University of Birmingham
Co-authored papers 2
Co-authored papers 2
Sydney Institute for Infectious Diseases, The University of Sydney
Co-authored papers 1
Bonita Vista High School, University of California San Diego, University of California, San Diego
Co-authored papers 1
University of California
Co-authored papers 1
The Scripps Research Institute
Co-authored papers 1
Co-authored papers 1
Korea University College of Medicine
Co-authored papers 1
Malaysia Genome and Vaccine Institute, National Institute of Biotechnology Malaysia
Co-authored papers 1
Malaysia Genome and Vaccine Institute
Co-authored papers 1
Tulane University School of Medicine
Co-authored papers 1
University of California-San Francisco
Co-authored papers 1
University of California
Co-authored papers 1
University of Arizona
Co-authored papers 1
the Scripps Research Institute
Co-authored papers 1
Hospital Germans Trias i Pujol
Co-authored papers 1
Co-authored papers 1
The Scripps Research Institute
Co-authored papers 1
The Scripps Research Institute
Co-authored papers 1